{"entity":{"type":"insider","cik":"0001840056","url":"/insider/0001840056","json_url":"/insider/0001840056.json","name":"Jones Cecilia","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":11,"first":"2023-06-30","last":"2026-04-06","span_basis":"filed_date"},"name_variants":[{"name":"Jones Cecilia","source":"filing","n_filings":11,"first_seen":"2023-06-30","last_seen":"2026-04-06"}],"transactions":[{"id":5862092,"accession":"0001439222-26-000063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000063","line_url":"/filing/0001439222-26-000063#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3141.0,"shares_display":"3,141","price_per_share":34.71,"price_display":"34.71","price_state":"stated","total_value":109024.11,"total_display":"109,024.11","total_whole":"109,024","shares_owned_after":54998.0,"shares_owned_after_display":"54,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-06","scope":"insider"},{"id":5844389,"accession":"0001439222-26-000038","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001439222-26-000038","line_url":"/filing/0001439222-26-000038","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5035.0,"shares_display":"5,035","price_per_share":28.96,"price_display":"28.96","price_state":"stated","total_value":145813.6,"total_display":"145,813.60","total_whole":"145,814","shares_owned_after":42785.0,"shares_owned_after_display":"42,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider","n_lines":4},{"id":6021196,"accession":"0001439222-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000002","line_url":"/filing/0001439222-26-000002#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2932.0,"shares_display":"2,932","price_per_share":27.09,"price_display":"27.09","price_state":"stated","total_value":79427.88,"total_display":"79,427.88","total_whole":"79,428","shares_owned_after":37394.0,"shares_owned_after_display":"37,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-30","filed_date":"2026-01-02","scope":"insider"},{"id":4040412,"accession":"0001439222-25-000104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000104","line_url":"/filing/0001439222-25-000104#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3651.0,"shares_display":"3,651","price_per_share":36.77,"price_display":"36.77","price_state":"stated","total_value":134247.27,"total_display":"134,247.27","total_whole":"134,247","shares_owned_after":33870.0,"shares_owned_after_display":"33,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-09-30","scope":"insider"},{"id":4964497,"accession":"0001439222-25-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000067","line_url":"/filing/0001439222-25-000067#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":33.54,"price_display":"33.54","price_state":"stated","total_value":59701.2,"total_display":"59,701.20","total_whole":"59,701","shares_owned_after":30049.0,"shares_owned_after_display":"30,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider"},{"id":4330207,"accession":"0001439222-25-000019","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-25-000019","line_url":"/filing/0001439222-25-000019","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2275.0,"shares_display":"2,275","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":80853.5,"total_display":"80,853.50","total_whole":"80,854","shares_owned_after":25829.0,"shares_owned_after_display":"25,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider","n_lines":2},{"id":2354903,"accession":"0001439222-24-000129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000129","line_url":"/filing/0001439222-24-000129#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2542.0,"shares_display":"2,542","price_per_share":49.03,"price_display":"49.03","price_state":"stated","total_value":124634.26,"total_display":"124,634.26","total_whole":"124,634","shares_owned_after":20158.0,"shares_owned_after_display":"20,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider"},{"id":2911398,"accession":"0001439222-24-000052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000052","line_url":"/filing/0001439222-24-000052#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":672.0,"shares_display":"672","price_per_share":32.57,"price_display":"32.57","price_state":"stated","total_value":21887.04,"total_display":"21,887.04","total_whole":"21,887","shares_owned_after":14840.0,"shares_owned_after_display":"14,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-05","scope":"insider"},{"id":2759202,"accession":"0001439222-24-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000018","line_url":"/filing/0001439222-24-000018#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1886.0,"shares_display":"1,886","price_per_share":21.64,"price_display":"21.64","price_state":"stated","total_value":40813.04,"total_display":"40,813.04","total_whole":"40,813","shares_owned_after":13069.0,"shares_owned_after_display":"13,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-24","scope":"insider"},{"id":8653195,"accession":"0001439222-23-000133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000133","line_url":"/filing/0001439222-23-000133#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2179.0,"shares_display":"2,179","price_per_share":24.79,"price_display":"24.79","price_state":"stated","total_value":54017.41,"total_display":"54,017.41","total_whole":"54,017","shares_owned_after":9575.0,"shares_owned_after_display":"9,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-09-28","scope":"insider"},{"id":8299596,"accession":"0001439222-23-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000101","line_url":"/filing/0001439222-23-000101#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001840056","owner_name":"Jones Cecilia","owner_display_name":"Jones Cecilia","owner_url":"/insider/0001840056","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1597.0,"shares_display":"1,597","price_per_share":28.36,"price_display":"28.36","price_state":"stated","total_value":45290.92,"total_display":"45,290.92","total_whole":"45,291","shares_owned_after":3783.0,"shares_owned_after_display":"3,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Officer (Chief Financial Officer)","n_filings":11,"first_seen":"2023-06-30","last_seen":"2026-04-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001840056","retrieved_at":"2026-08-25T10:45:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}